Kentucky Pharmaceuticals, Inc.

Saint Louis, MO 63108

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.08MM
First Award Date 11/01/09
Most Recent Award Date 06/10/16

Key Personnel

Last Name Name Awards Contact
Olson Paul K Olson 2
Kaplan Henry Jerrold Kaplan 1
SCHMIDT MARTIN J. SCHMIDT 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-052
Budget: 06/10/16 - 05/31/17

? DESCRIPTION (provided by applicant): Despite overwhelming evidence that the complement system is involved in kidney and cardiovascular outcomes, stringent technical requirements limit its inclusion in clinical trials and diagnostics. Current protocols require careful sample collectin, immediate freezing, and shipping to only a few specialize...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 07/01/11 - 06/30/13

DESCRIPTION (provided by applicant): The purpose of this SBIR project is to develop a new dual-modality inflammation imaging technology to early detect Uveitis, an ocular inflammation-related disorder. This technology, based on nanocomposites (NCs) that function as dual-modality fluorescent and acoustic contrast agents for optical and ultraso...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-OD-09-009
Budget: 06/01/10 - 05/31/12

DESCRIPTION (provided by applicant): The goal of this project is to develop a lateral flow assay for detecting complement levels and complement activation status in a patient. This assay will give results in seconds versus either hours or days that normal complement lab assays have. It also will give more accurate results than conventional assay...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-07-281
Budget: 11/01/09 - 06/30/12

DESCRIPTION (provided by applicant): The purpose of this Phase II STTR project is to develop a nanoparticle-based drug delivery system for use in the treatment of dry age-related macular degeneration (AMD). AMD is the leading cause of blindness for individuals over fifty-five years of age that live in the industrialized world, affecting approxim...